365 SKINNY High Intensity Capsules, 600 mg, 30-count bottle, BODY BALANCE INTERNACIONAL
Published February 23, 2022 · Recall initiated: August 2, 2021
Summary
FDA records drug Class I recall D-0631-2022, published February 23, 2022 and initiated August 2, 2021. Recalling firm: Je Dois Lavoir LLC; Status: Terminated; Reported quantity: 783 bottles; Lot: Lot 102-26, Exp Dec 2022. Class I means a reasonable probability of serious adverse health consequences or death.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Marketed Without an Approved NDA/ANDA: FDA analysis found the product to be tainted with undeclared sibutramine, a previously approved drug that was withdrawn from the US market due to safety concerns.
What to do
Voluntary: Firm initiated · Press Release
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Je Dois Lavoir LLC
- Distributor
- Sold online via website nationwide in the USA and Canada.
- Lot
- Lot 102-26, Exp Dec 2022
- Risk classification
- Class I
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDATHE RED PILL, EXTRA STRENGTH capsules, 800 mg, packaged in 10-count blisters packaged in a carton, ASINFebruary 23, 2022
- FDAHYDROmorphone HCl PF 10 mg/50 mL (0.2mg/mL) in NaCl, 50 mL in 50 mL Single Dose Syringe, Rx only, STAQ Pharma,February 23, 2022
- FDAChlorthalidone Tablets USP 25 mg, Rx Only, 100 Tablets, Sun Pharma, Mfg. by: Fontida Bio Pharm Inc., 1100February 23, 2022
- FDAMorphine Sulfate PF 25 mg/25mL (1 mg/mL) in NaCl, 25 mL in 30 mL Single Dose Syringe, Rx only, STAQ Pharma,February 23, 2022
- FDAPyrazinamide Tablets, USP 500 mg, 100-count bottles, Rx only, Manufactured by: ULTRAtab Laboratories, Inc.February 23, 2022
- FDARED MAMMOTH capsules, 400 mg, packaged in 10-count blisters per carton, ASIN B00KA8FBNI, barcode X001ANE0I5.February 23, 2022
Questions about this recall
Was 365 SKINNY High Intensity Capsules, 600 mg, 30-count bottle, BODY BALANCE INTERNACIONAL recalled?
Yes. FDA published recall D-0631-2022 on February 23, 2022. Reported hazard: Marketed Without an Approved NDA/ANDA: FDA analysis found the product to be tainted with undeclared sibutramine, a previously approved drug that was withdrawn from the US market due to safety concerns.
What should I do if I have this product?
Voluntary: Firm initiated · Press Release